Abstract: The present invention is directed to a composition and method for detecting intestinal deficiency. In particular, a 13C-?-limit dextrin that is specifically hydrolyzed by brush border intestinal enzymes is disclosed herein. The 13C-?-limit dextrin as disclosed herein may be used as a substrate in a bi-phasic breath test to detect intestinal glucoamylase deficiency and/or abnormal brush border intestinal enzyme activity.

Abstract: Disclosed is milk lactoferrin as a dietary ingredient which promotes growth of the gastrointestinal tract of human infants and newborn nonhuman animals immediately on birth when added to an infant formula or given separately as a dietary supplement thus reducing chronic diarrhea, assisting in the management of short gut syndrome, and avoiding, at least to some extent, chronic intractable diarrhea of the infant.

Abstract: Disclosed is an improved dietary protein mineral module composed of a high quality protein, such as calcium-sodium caseinate, and electrolytes (minerals) combined in a fixed ratio so that when the protein concentration in water is 2.2 g/100 cc (a normal concentration) the normal mineral requirements are met and in which the dietary acid content (chloride) is reduced to a maximum of 2.0% dry weight and there is increased phosphorus content (a minimum of 1.0% up to 4.0% dry weight). The improved module has been quite successful in treating specific problems in infants who have not responded well to any of the existing commercial formulas. These include: acquired monosaccharide intolerance or intractable diarrhea of infancy; weaning from total parental nutrition; alteration of the renal solute load in infants with renal or congenital heart disease; and prevention of acidosis in infants thereby resulting in better growth.